转移增强蛋白 KITENIN 通过上调肿瘤干细胞标志物赋予替莫唑胺对未甲基化 MGMT 的胶质母细胞瘤的耐药性.
Mesh : Glioblastoma / drug therapy genetics metabolism pathology Temozolomide / therapeutic use pharmacology Humans Neoplastic Stem Cells / drug effects metabolism DNA Modification Methylases / metabolism genetics DNA Repair Enzymes / genetics metabolism Drug Resistance, Neoplasm / drug effects genetics Up-Regulation / drug effects Tumor Suppressor Proteins / genetics metabolism Antineoplastic Agents, Alkylating / therapeutic use pharmacology
来 源: DOI:10.1002/ctm2.1804 PDF(Pubmed)